Life Sciences Tools and Services
Company Overview of American Stem Cell Corporation
American Stem Cell Corporation, a development stage company, intends to evaluate, acquire, integrate, and commercialize stem cell technologies and therapies. It focuses on human cell therapy, which includes the production of human differentiated cells from stem cells and involves the use of nuclear transfer technology, human oocytes, and embryonic material. The company was incorporated in 2005 and is based in Los Angeles, California.
11300 West Olympic Boulevard
Los Angeles, CA 90064
Founded in 2005
Key Executives for American Stem Cell Corporation
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact American Stem Cell Corporation, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.